Under-expression of EHD2 mRNA and EHD2 protein has been observed in different cancers, including esophageal squamous cells carcinoma, breast cancer, glioma, and serous ovarian cancers compared to normal tissue samples [18–21]. Here, EHD2 is linked to esophageal squamous cell carcinoma.